Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SEMI-IMPLANTABLE AND FULLY IMPLANTABLE MIDDLE EAR HEARING AIDS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AUTOMATED VISUAL EVOKED POTENTIALS FOR ROUTINE VISION SCREENING IN PEDIATRICS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RETINAL POLARIZATION SCAN (RETINAL BIREFRINGENCE SCANNING) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYELOPEROXIDASE (MPO) IMMUNOASSAY FOR CARDIAC DISEASE RISK - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE GROWTH STIMULATION ULTRASOUND ACCELERATED FRACTURE HEALING DEVICE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROGRAMS FOR DISORDERS OF CONSCIOUSNESS (DOC) (EFFECTIVE 09/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC RESONANCE IMAGING - TARGETED BIOPSY OF THE PROSTATE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPINAL SURGERY-MINIMALLY INVASIVE LUMBAR INTERBODY FUSION (-LIF) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT- HEMATOPOIETIC CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CRANIAL ORTHOSIS (HELMET OR BAND THERAPY) AS A TREATMENT OF PLAGIOCEPHALY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - MOZOBIL (PLERIXAFOR) (RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), INCLUDING SUBCUTANEOUS ICD) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TANEZUMAB SUBCUTANEOUS INJECTION - RETIRED AS 04/14/2022 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DIGITAL HEALTH TECHNOLOGIES: THERAPEUTIC APPLICATIONS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - ALIQOPA (COPANLISIB) (RETIRED AS OF 04/10/2024) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW - HEMATOPOIETIC CELL TRANSPLANT FOR WALDENSTROM'S MACROGLOBULINEMIA | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | STEM CELL THERAPY IN THE TREATMENT OF PERIPHERAL ARTERY DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SENSORY INTEGRATION AND AUDITORY INTEGRATION THERAPY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NAVIGATED TRANSCRANIAL MAGNETIC STIMULATION (NTMS) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ANNULAR CLOSURE DEVICES (E.G., BARRICAID, XCLOSE, INCLOSE) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCBSM ONLY: HOME OXYGEN EQUIPMENT AND RELATED SUPPLIES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POLYMERASE CHAIN REACTION (PCR) TESTING IN THE DIAGNOSIS OF ONYCHOMYCOSIS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR HODGKIN LYMPHOMA | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | THERMAL TREATMENTS FOR DRY EYE SYNDROME - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR NON-HODGKIN LYMPHOMAS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVENOUS ANESTHETICS FOR THE TREATMENT OF CHRONIC PAIN AND PSYCHIATRIC DISORDERS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR TAY-SACHS DISEASE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW HEMATOPOIETIC CELL TRANSPLANTATION FOR PRIMARY AMYLOIDOSIS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RADIOEMBOLIZATION FOR PRIMARY AND METASTATIC TUMORS OF THE LIVER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | VERTEBRAL BODY TETHERING AND/OR STAPLING FOR SCOLIOSIS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC RESONANCE SPECTROSCOPY (EFFECTIVE 07/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR CHRONIC MYELOID LEUKEMIA | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MOLECULAR TESTING FOR CHRONIC HEART FAILURE AND HEART TRANSPLANT | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | STEREOTACTIC RADIOSURGERY AND STEREOTACTIC BODY RADIOTHERAPY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EX VIVO LUNG PERFUSION (EVLP) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCUTANEOUS ELECTRICAL MODULATION PAIN REPROCESSING (SCRAMBLER THERAPY) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PERORAL ENDOSCOPIC MYOTOMY FOR TREATMENT OF ESOPHAGEAL ACHALASIA GASTROPARESIS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | VERTICAL EXPANDABLE PROSTHETIC TITANIUM RIB - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MORPHOGENETIC PROTEIN (EFFECTIVE 09/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NEAR INFRARED SPECTROSCOPY FOR WOUND EXAMINATION - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SURGICAL DEACTIVATION OF HEADACHE TRIGGER SITES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EXTRACORPOREAL SHOCK WAVE TREATMENT OF WOUNDS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ABSORBABLE NASAL IMPLANT FOR TREATMENT OF NASAL VALVE COLLAPSE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCBSM ONLY: APPROVED OFF LABEL DRUG USE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HERCEPTIN HYLECTA (TASTUZUMAB AND HYALURONIDASE-OYSK FOR SUBCUTANEOUS INJECTION) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AZEDRA (IOBENGUANE) - retired as of 06/06/2024 Mlackley | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PATIENT-SPECIFIC CUTTING GUIDES AND CUSTOM KNEE IMPLANTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ORTHOPEDIC APPLICATIONS OF PLATELET-RICH PLASMA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MOLECULAR TESTING IN THE MANAGEMENT OF PULMONARY NODULES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - GENE EXPRESSION PROFILING FOR UVEAL MELANOMA | New policy |